Alireza Rezvani, Ahmad Monabati, Zahra Kargar, Akbar Safaei, Mahdi Mahmoodzadeh, Hamideh Moosapour, Marzieh Hosseini, Abdolmajid Taheri, Soleiman Kheiri, Elham Taheri
BACKGROUND & OBJECTIVE: Some of the patients with myelodysplastic syndrome (MDS) are categorized as good prognosis based on the Revised International Prognostic Scoring System (IPSS-R). However, these patients may have poor clinical outcomes. It seems that the current diagnostic tools and IPSS-R cannot consider genetic factors for determining the prognosis of MDS patients. METHODS: This cross-sectional study included all adult MDS patients of both genders who were admitted from March 2015 to March 2020 to the Hematology wards of two educational tertiary hospitals in Iran (Namazi and Faghihi, affiliated with Shiraz University of medical sciences)...
2023: Iranian Journal of Pathology